...
机译:在与高剂量的细胞酸和利妥昔单抗组合的自体移植组合之前的oxaliplatin提供比甲状腺细胞淋巴瘤患者的顺铂或卡铂的更长的疾病控制:Lyma前瞻性试验结果
Nantes Univ Hosp Dept Clin Hematol Nantes France;
Nantes Univ Angers Univ CNRS CRCINA INSERM Nantes France;
Hop St Louis AP HP Hemato Oncol Paris France;
Purpan Univ Hosp Dept Clin Hematol Toulouse France;
Bordeaux Univ Hosp Dept Clin Hematol Bordeaux France;
Tours Univ Hosp Dept Clin Hematol Tours France;
Amiens Univ Hosp Dept Clin Hematol Amiens France;
Inst Gustave Roussy Dept Hematol Villejuif France;
Grenoble Univ Hosp Dept Clin Hematol Grenoble France;
Nancy Univ Hosp Dept Clin Hematol INSERM Nancy France;
Ctr Hospitalier Univ Dijon Serv Hematol Clin INSERM UMR1231 Dijon France;
Ctr Hosp dAvignon Dept Hematol Avignon France;
Hop Henri Mondor AP HP Unite Hemopathies Lymphoides Creteil France;
Vendee Hosp Ctr Dept Clin Hematol La Roche Sur Yon France;
LYSARC Dept Biostat Lyon France;
Univ Louvain Clin Univ St Luc Brussels Belgium;
Rennes Univ Hosp Dept Clin Hematol MICA Res Unit Rennes France;
Univ Rouen Dept Hematol Ctr Henri Becquerel INSERM U1245 Rouen France;
Nantes Univ Hosp Dept Pathol Nantes France;
Univ Paris 05 Inst Imagine Hop Necker AP HP Paris France;
Nantes Univ Hosp Dept Clin Hematol Nantes France;
机译:利妥昔单抗,苯达莫司汀和阿糖胞苷联合治疗不适合强化治疗或自体移植的套细胞非霍奇金淋巴瘤患者
机译:非霍奇金淋巴瘤合并中枢神经系统患者大剂量利妥昔单抗联合大剂量阿糖胞苷动员疗法和大剂量噻托帕,白消安和环磷酰胺自体干细胞移植的2期试验
机译:相2试验高剂量蓖麻毒素动员治疗和高剂量Thiotepa,Busulfan和环磷酰胺自体干细胞移植患者,中枢神经系统受到非霍奇金淋巴瘤的患者
机译:逆转录病毒介导的人MDR-1转移的第1期试验在接受高剂量化疗和自体干细胞移植的患者中
机译:非霍奇金淋巴瘤累及中枢神经系统患者的大剂量利妥昔单抗联合大剂量阿糖胞苷动员疗法和大剂量噻托帕白消安和环磷酰胺(R-TBC)自体干细胞移植的II期试验
机译:高剂量蓖麻毒素动员治疗和高剂量Thiotepa,Busulfan和环磷酰胺自体干细胞移植患者中枢神经系统的患者的相2试验,非霍奇金淋巴瘤